Plunkett Research Online: Seelos Therapeutics Inc

SEELOS THERAPEUTICS INC (SEEL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders......



Seelos Therapeutics Inc
Ticker: SEEL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 646-293-2100
Fax:
Address: 300 Park Avenue
2nd Floor
New York, NY 10022 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Delivery Systems
Biopharmaceuticals
Clinical-Stage Development
Novel Therapeutics
Contacts Description
Raj MehraCEO/Director/President
Michael GolembiewskiCFO/Chief Accounting Officer
See More
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders......See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
SLS-002
SLS-004
SLS-005
SLS-006
SLS-007
SLS-008
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: